Medigus Ltd.
13F holders, Q2 2024 (June 30)5holders +1
1new positions
0sold out
$1.80avg. 13F price*
At the end of Q2 2024, 5 institutions reported holding Medigus Ltd. in their 13F filings, up 1 from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were UBS Group AG ($11K), Rhumbline Advisers ($2K) and Osaic Holdings, Inc. ($568).
- Company
- Medigus Ltd.
- CUSIP
- 58471G409
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $11 |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 5,741 shares bought and 1,880 shares sold, net +3,861 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| UBS Group AG | 0.00% | Add +3168.5% | 5,916 | $11K |
| Rhumbline Advisers | 0.00% | Reduce -12.5% | 1,263 | $2K |
| Osaic Holdings, Inc. | 0.00% | No change | 316 | $568 |
| Morgan Stanley | 0.00% | Reduce -98.8% | 21 | $39 |
| Global Wealth Strategies & Associates | 0.00% | New | 6 | $11 |
"% of holder's portfolio" is MEDIGUS LTD's weight in each manager's 13F, not the share of Medigus Ltd. the manager owns.